Effects of 12 weeks of probiotic supplementation on quality of life in colorectal cancer survivors: A double-blind, randomized, placebo-controlled trial

Digestive and Liver Disease

Volumn 46, Issue 12, 2014, Pages 1126-1132

  Lee, Jee Yon ^a   Chu, Sang Hui ^b   Jeon, Justin Y ^b   Lee, Mi Kyung ^b   Park, Ji Hye ^b   Lee, Duk Chul ^a   Lee, Ji Won ^a   Kim, Nam Kyu ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

Bowel symptoms; Cancer survivors; Colorectal cancer; Probiotics

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

ADULT; ARTICLE; ASSESSMENT OF HUMANS; CANCER SURVIVOR; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FATIGUE; FEMALE; FUNCTIONAL ASSESSMENT OF CANCER THERAPY SCORE; HUMAN; IRRITABLE COLON; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS RHAMNOSUS; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; WELLBEING; AGED; COLORECTAL TUMOR; COMPLICATION; IRRITABLE BOWEL SYNDROME; MIDDLE AGED; SURVIVOR; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PROBIOTICS; QUALITY OF LIFE; SURVIVORS; TREATMENT OUTCOME;

EID: 84930712312     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2014.09.004     Document Type: Article

References (51)

1. Lertkhachonsuk A.-A., Yip C.H., Khuhaprema T., et al. Cancer prevention in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013. Lancet Oncology 2013, 14:e497-e507.
2. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA: A Cancer Journal for Clinicians 2008, 58:71-96.
3. Phipps E., Braitman L.E., Stites S., et al. Quality of life and symptom attribution in long-term colon cancer survivors. Journal of Evaluation in Clinical Practice 2008, 14:254-258.
4. Vironen J.H., Matti Kairaluoma M., Aalto A.-M., et al. Impact of functional results on quality of life after rectal cancer surgery. Diseases of the Colon and Rectum 2006, 49:568-578.
5. Camilleri-Brennan J., Steele R. Quality of life after treatment for rectal cancer. British Journal of Surgery 1998, 85:1036-1043.
6. Scheer A.S., Boushey R.P., Liang S., et al. The long-term gastrointestinal functional outcomes following curative anterior resection in adults with rectal cancer: a systematic review and meta-analysis. Diseases of the Colon and Rectum 2011, 54:1589-1597.
7. Ho Y.H., Low D., Goh H.-S. Bowel function survey after segmental colorectal resections. Diseases of the Colon and Rectum 1996, 39:307-310.
8. Bregendahl S., Emmertsen K.J., Lous J., et al. Bowel dysfunction after low anterior resection with and without neoadjuvant therapy for rectal cancer: a population-based cross-sectional study. Colorectal Disease 2013, 15:1130-1139.
9. Yang L., Pei Z. Bacteria, inflammation, and colon cancer. World Journal of Gastroenterology 2006, 12:6741.
10. Guandalini S. Probiotics for children with diarrhea: an update. Journal of Clinical Gastroenterology 2008, 42:S53-S57.
11. Saavedra J.M., Bauman N., Perman J., et al. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. The Lancet 1994, 344:1046-1049.
12. Bai A., Ouyang Q. Probiotics and inflammatory bowel diseases. Postgraduate Medical Journal 2006, 82:376-382.
13. Brenner D.M., Moeller M.J., Chey W.D., et al. The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review. American Journal of Gastroenterology 2009, 104:1033-1049.
14. McFarland L.V., Dublin S. Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World Journal of Gastroenterology 2008, 14:2650.
15. Saggioro A. Probiotics in the treatment of irritable bowel syndrome. Journal of Clinical Gastroenterology 2004, 38:S104-S106.
16. Yoon J.S., Sohn W., Lee O.Y., et al. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. Journal of Gastroenterology and Hepatology 2014, 29:52-59.
17. Bengmark S. Ecological control of the gastrointestinal tract. The role of probiotic flora. Gut 1998, 42:2-7.
18. Menard S., Candalh C., Bambou J., et al. Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport. Gut 2004, 53:821-828.
19. Pathmakanthan S., Li C.K., Cowie J., et al. Lactobacillus plantarum 299: beneficial in vitro immunomodulation in cells extracted from inflamed human colon. Journal of Gastroenterology and Hepatology 2004, 19:166-173.
20. Ohigashi S., Hoshino Y., Ohde S., et al. Functional outcome, quality of life, and efficacy of probiotics in postoperative patients with colorectal cancer. Surgery Today 2011, 41:1200-1206.
21. Longstreth G.F., Thompson W.G., Chey W.D., et al. Functional bowel disorders. Gastroenterology 2006, 130:1480-1491.
22. Cella D.F., Tulsky D.S., Gray G., et al. The functional assessment of cancer therapy scale: development and validation of the general measure. Journal of Clinical Oncology 1993, 11:570-579.
23. Kroenke K., Spitzer R.L. The PHQ-9: a new depression diagnostic and severity measure. Psychiatric Annals 2002, 32:1-7.
24. Sekine K., Toida T., Saito M., et al. A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumor in mice. Cancer Research 1985, 45:1300-1307.
25. Matsuzaki T. Immunomodulation by treatment with Lactobacillus casei strain Shirota. International Journal of Food Microbiology 1998, 41:133-140.
26. Lee J.W., Kim E.H., Yim I.B., et al. Immunomodulatory and antitumor effects in vivo by the cytoplasmic fraction of Lactobacillus casei and Bifidobacterium longum. Journal of Veterinary Science 2004, 5:41-48.
27. Morotomi M., Mutal M. In vitro binding of potent mutagenic pyrolyzates to intestinal bacteria. Journal of the National Cancer Institute 1986, 77:195-201.
28. Liu Z., Qin H., Yang Z., et al. Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery - a double-blind study. Alimentary Pharmacology and Therapeutics 2011, 33:50-63.
29. Bittorf B., Stadelmaier U., Göhl J., et al. Functional outcome after intersphincteric resection of the rectum with coloanal anastomosis in low rectal cancer. European Journal of Surgical Oncology 2004, 30:260-265.
30. Weeks J.C., Nelson H., Gelber S., et al. Short-term quality-of-life outcomes following laparoscopic-assisted colectomy vs open colectomy for colon cancer. Journal of the American Medical Association 2002, 287:321-328.
31. Lee E.-H., Chun M., Kang S., et al. Validation of the Functional Assessment of Cancer Therapy-General (FACT-G) scale for measuring the health-related quality of life in Korean women with breast cancer. Japanese Journal of Clinical Oncology 2004, 34:393-399.
32. Yoo H.J., Kim J.C., Eremenco S., et al. Quality of life in colorectal cancer patients with colectomy and the validation of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C), Version 4. Journal of Pain and Symptom Management 2005, 30:24-32.
33. Moore W., Moore L.H. Intestinal floras of populations that have a high risk of colon cancer. Applied and Environment Microbiology 1995, 61:3202-3207.
34. Horie H., Kanazawa K., Kobayashi E., et al. Effects of intestinal bacteria on the development of colonic neoplasm II. Changes in the immunological environment. European Journal of Cancer Prevention 1999, 8:533-538.
35. Goulet O., Joly F. Intestinal microbiota in short bowel syndrome. Gastroentérologie clinique et biologique 2010, 34:S37-S43.
36. Wardill H.R., Bowen J.M., Gibson R.J. Chemotherapy-induced gut toxicity: are alterations to intestinal tight junctions pivotal. Cancer Chemotherapy and Pharmacology 2012, 70:627-635.
37. Wardill H.R., Bowen J.M. Chemotherapy-induced mucosal barrier dysfunction: an updated review on the role of intestinal tight junctions. Current Opinion in Supportive and Palliative Care 2013, 7:155-161.
38. Guarner F., Malagelada J-R. Gut flora in health and disease. Lancet 2003, 361:512-519.
39. Grimoud J., Durand H., De Souza S., et al. In vitro screening of probiotics and synbiotics according to anti-inflammatory and anti-proliferative effects. International Journal of Food Microbiology 2010, 144:42-50.
40. De Giorgio R., Barbara G. Is irritable bowel syndrome an inflammatory disorder. Current Gastroenterology Reports 2008, 10:385-390.
41. Muzes G., Molnár B., Tulassay Z., et al. Changes of the cytokine profile in inflammatory bowel diseases. World Journal of Gastroenterology 2012, 18:5848.
42. Barbara G., Cremon C., Carini G., et al. The immune system in irritable bowel syndrome. Journal of Neurogastroenterology and Motility 2011, 17:349-359.
43. Spiller R., Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology 2009, 136:1979-1988.
44. Mayer E.A. Gut feelings: the emerging biology of gut-brain communication. Nature Reviews Neuroscience 2011, 12:453-466.
45. Bercik P., Collins S., Verdu E. Microbes and the gut-brain axis. Neurogastroenterology and Motility 2012, 24:405-413.
46. Benton D., Williams C., Brown A. Impact of consuming a milk drink containing a probiotic on mood and cognition. European Journal of Clinical Nutrition 2006, 61:355-361.
47. Rao A.V., Bested A.C., Beaulne T.M., et al. A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathogens 2009, 1:1-6.
48. Singh P., Chopra K., Kuhad A., et al. Role of Lactobacillus acidophilus loaded floating beads in chronic fatigue syndrome: behavioral and biochemical evidences. Neurogastroenterology and Motility 2012, 24:366-e170.
49. Wagner L., Cella D. Fatigue and cancer: causes, prevalence and treatment approaches. British Journal of Cancer 2004, 91:822-828.
50. Mitchell A.J., Ferguson D.W., Gill J., et al. Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. Lancet Oncology 2013, 14:721-732.
51. Gianotti L., Morelli L., Galbiati F., et al. A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients. World Journal of Gastroenterology 2010, 16:167.